Advanced drug delivery market to grow by $ 195.13 billion globally by 2030 at a CAGR of 16.0%


Rising prevalence of chronic disorders requiring the use of drug delivery systems, advancements and developments in technology, and increasing spending on healthcare are driving the global advanced drug delivery market

PORTLAND, Ore., January 10, 2022 / PRNewswire / – Allied Market Research recently released a report titled, Advanced Drug Delivery Market by product type (drug eluting lens, microneedle patch, hydrogel drug delivery and Nano transporter) and End User (Hospitals, Specialty Clinics and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 “. According to the report, the size of the global advanced drug delivery market has been taken into account $ 44.02 billion in 2020, and is expected to reach 195.13 billion dollars by 2030, with a CAGR of 16.0% from 2021 to 2030.

Allied Market Research Logo

For a good perspective and competitive insight, get a sample report on:

https://www.alliedmarketresearch.com/request-sample/15153

Main determinants of market growth

Rising prevalence of chronic disorders requiring the use of drug delivery systems, advancements and developments in technology, and increasing spending on healthcare are driving the global advanced drug delivery market. However, increasing number of drug recalls and drug failures is hampering the growth of the market. On the contrary, the growth potential of emerging markets opens up new opportunities for the future.

Covid-19 scenario:

  • The Covid-19 pandemic has positively impacted the demand for advanced drug delivery systems. Due to the increase in the number of patients with Covid-19, a large number of hospitals and clinics have been recognized to increase hospital capacity.

  • The pandemic has encouraged R&D activities and increased clinical trials of efficacy and safety for the treatment of vaccination against Covid-19.

  • However, the lockdown hampered the transport and manufacture of crucial hospital supplies.

Nanotransporters segment dominated the market

By product type, the nanotransporters segment held the largest share in 2020, accounting for over four-fifths of the global advanced drug delivery market, due to increasing availability of drugs of lower toxicity. and effective targeted therapy, and decrease in active drug degradation. . However, the drug-eluting lens segment is estimated to register the highest CAGR of 24.1% during the forecast period, due to the increased bioavailability of the drugs compared to traditional methods such as eye drops.

Do you have a specific question or requirement? Ask our industry expert: https://www.alliedmarketresearch.com/purchase-enquiry/15153

The hospital segment to represent the highest CAGR until 2030

By end-user, the hospital segment is expected to post the highest CAGR of 16.9% from 2021 to 2030, driven by the increase in the number of inpatient and outpatient visits. However, the specialty clinic segment held the largest share in 2020, contributing almost half of the global advanced drug delivery market, due to the increase in chronic diseases such as neurology, oncology, orthopedics and increasing demand for drug administration treatment.

North America held the lion’s share

By region, the market across North America dominated in 2020, accounting for more than two-fifths of the global advanced drug delivery market, due to the adoption of advanced technologies and a robust R&D infrastructure for scientific researchers. However, the market through Asia Pacific is expected to post the highest CAGR of 18.6% over the forecast period, due to government support for R&D activities in the pharmaceutical and biotechnology sectors and increased public-private investment.

Major market players

  • Alnylam Pharmaceuticals Inc.

  • Bausch Health Companies Inc. (Bausch & Lomb)

  • Altaris Capital Partners Llc. (Kindeva drug delivery)

  • Endo International Plc.

  • Biogen Limited

  • Microtip technologies

  • Johnson & Johnson (Johnson & Johnson Vision)

  • Ocular Therapeutics Inc.

  • Novo Nordisk A / S

  • Takeda Pharmaceutical Company Limited.

Basic Avenue map | Access to the library | One year subscription |

Sign up for the Avenue subscription to access over 12,000 company profiles and over 2,000 niche market research reports at $ 699 per month, per seat. For one year, the customer must purchase a minimum package of 2 places.

14-day free trial request: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published some syndicated market research in the same area that you may be interested in. Below is the report title for your reference., given the impact of Covid-19 on this market which will help you assess the aftermath of the pandemic on the short and long term growth trends of this market. “

Healthcare Trend Reports (book now with 10% discount):

Injectable Drug Delivery Market – Global Opportunity Analysis and Industry Forecast, 2020-2028

Implantable Drug Delivery Devices Market Global Opportunity Analysis and Industry Forecast 2019-2028

Drug Delivery Technology Market Global Opportunity Analysis and Industry Forecast 2019-2028

Nasal Drug Delivery Technologies Market Global Opportunity Analysis and Industry Forecast 2019-2028

Pharmaceutical Drugs Delivery Market Global Opportunity Analysis and Industry Forecast, 2019-2028

Drug Delivery Devices Market Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan kumar, CEO of Allied Market Research, leads the organization towards delivering high quality data and information. We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Each of the data presented in the reports we publish is taken from primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.

Contact:

David Corréa
5933 NE Win Sivers Drive
# 205, Portland, OR 97220
United States
United States/Canada (Free): + 1-800-792-5285, + 1-503-894-6022
UK: + 44-845-528-1300
Hong Kong: + 852-301-84916
India (Pune): + 91-20-66346060
Fax: +1(855)550-5975
[email protected]
The Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/advanced-drug-delivery-market-to-grow-195-13-billion-globally-by-2030-at-16-0-cagr – 301457028.html

SOURCE Allied market research

Previous Wizards' Hachimura delighted to play first game this season: "I missed the feeling"
Next $ 5,834.02 Million Medical Laser Systems Market Size, Worldwide, by 2028 at 13.5% CAGR